Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,176 | 1,845 | -5,163 | 4,685 | -7,823 |
| Accounts payable and accrued liabilities | 96 | N/A | N/A | N/A | N/A |
| Other Working Capital | 120 | -365 | 280 | -81 | 116 |
| Other Operating Activity | 261 | -3,690 | 1,889 | -7,830 | 5,779 |
| Operating Cash Flow | $-1,699 | $-2,210 | $-2,994 | $-3,226 | $-1,928 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,343 | 1,570 | N/A | 2,566 | 7,190 |
| Financing Cash Flow | $2,343 | $1,570 | $N/A | $2,566 | $7,190 |
| Exchange Rate Effect | N/A | N/A | N/A | 10 | N/A |
| Beginning Cash Position | 1,663 | 2,303 | 5,297 | 5,947 | 685 |
| End Cash Position | 2,307 | 1,663 | 2,303 | 5,297 | 5,947 |
| Net Cash Flow | $644 | $-640 | $-2,994 | $-650 | $5,262 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,699 | -2,210 | -2,994 | -3,226 | -1,928 |
| Free Cash Flow | -1,699 | -2,210 | -2,994 | -3,226 | -1,928 |